Hims & Hers Health Inc. buy geldnutzer
Start price
03.12.24
/
60%
€30.77
Target price
03.12.25
€37.00
Performance (%)
-7.93%
End price
21.01.25
€28.33
Summary
This prediction ended on 21.01.25 with a price of €28.33. With a performance of -7.93%, the BUY prediction by geldnutzer finished with a loss. geldnutzer has a follow-up prediction for Hims & Hers Health Inc. where he still thinks Hims & Hers Health Inc. is a Buy. geldnutzer has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Hims & Hers Health Inc. | -5.851% | -5.851% | 10.223% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to geldnutzer what are the pros and cons of Hims & Hers Health Inc. for the foreseeable future?
Pros
EBIT growth >5% per year expected
Good rating
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Standard Investments for future growth
Future proof or reliable business model
Cons
Lower EBIT Margin than peer group
High valuation
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Sustainability is little important
high free float
Below average Marketposition
Significant cyclical dependencies
Revenue decline/stagnation expected
negative Cash Flow expected
Higher risks for its business
Unknown brand
Probably not worthwhile Investment
Very low/no dividend yield expected
Below average Management
Little innovation
Bad culture
Comments by geldnutzer for this prediction
In the thread Hims & Hers Health Inc. diskutieren
Buy mit Kursziel 37,0
In the thread Trading Hims & Hers Health Inc.
Buy beendet
Current prediction by geldnutzer for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€34.69
24.03.25
24.03.25
€44.00
24.03.26
24.03.26
-8.62%
12.12.25
12.12.25
EBIT growth >5% per year expected
Good rating
Lower EBIT Margin than peer group
High valuation
Stopped prediction by geldnutzer for Hims & Hers Health Inc.
Hims & Hers Health Inc.
Start price
Target price
Perf. (%)
€28.33
21.01.25
21.01.25
€25.00
21.01.26
21.01.26
22.45%
24.03.25
24.03.25
EBIT growth >5% per year expected
Good rating
Lower EBIT Margin than peer group
High valuation


